Stock News, US News

GOEV – The Tuesday Update (We’re on track!)

GOEV - The Tuesday Update (We're on track!)

Post 0 – https://www.reddit.com/r/wallstreetbets/comments/qs0l9c/goev_canoo_earnings_report_speculation/

Post 1 – https://www.reddit.com/r/wallstreetbets/comments/quja2a/goev_the_bang_bus_is_back_fuckshorts/

Fast points

  • We didn't get huge news. I was hoping for something like a LOI for a future partnership that would drive a lot of hype.
  • We did get some news. The company is opening a new HQ in Arkansas, a new testing facility, and are continuing to hire and move forward on the plant in Oklahoma. The fundamental bull case in this company remains unchanged, this stock is a good buy for the long run.
    • I hope this is scaring off the shorts
  • We got a jump on the news, we closed at $8.45 and opened at $9.20, now we're around $9.75 at time of writing. Daily high $9.97 already. $10.01 already. Lets go! πŸš€
  • People jumped all over contracts yesterday, and with the share price jump our thesis about ITM contracts continues to hold strong. $10 and $12.50 continue to be the breaking points.
  • Trading volume is still tight, strong buying power will continue to drive the stock up.
  • Too many calls still OTM, I know it's bad value but I recommend the "safer play" of 7c-9c so that we have more immediate pressure to deliver on the banks.
  • 1.4 million shares are ITM now bull thesis for the spike remains solid
  • Keep Buying Shares, Buy 7c, 8c, 9c to pressure the banks. 11c to build pressure between $10 and $12.50. 20c for the lotto
  • EDIT: We broke $10, keep pushing with buy pressure πŸ’ŽπŸ€²πŸ’Ž

https://preview.redd.it/bn6bo0bpizz71.jpg?width=828&format=pjpg&auto=webp&s=85f90967f9bec43ae5ce8db63485d1b831a2e300

https://preview.redd.it/v264517sczz71.png?width=371&format=png&auto=webp&s=3a4506b6d0c4327232c6bfe6d127297b55a99d6b

submitted by /u/officialbigrob
[link] [comments]

Jump To The Original Source

Facebook Comments

Check Also

BioNTech, Pfizer vaccine neutralises Omicron with three shots

Published by Reuters (Reuters) – BioNTech and Pfizer ...

Archives